PartnershipUpdated on 25 January 2026
BIOTECH: Finding funding to develop Novel Neuropsychiatric Drugs via Computational Multi-Target Drug Design
About
We would like to find potential strategic partnership for funding a co-development of Novel Neuropsychiatric Drugs via Computational Multi-Target Drug Design, aiming for treatment-resistant depression patients.
Similar opportunities
Partnership
BIOTECH: Finding a strategic partner to develop novel psychitric drugs
Dorit Cohen
Founder & CEO at ReSynapse Therapeutics
Nes Ziona, Israel
Partnership
Microrobotic Platform for Targeted CNS Drug Delivery
Arthur Piovezan
Business Development Lead at Robeauté
Paris, France
Partnership
Strategic partnerships for vascularized 3D tumour models in preclinical oncology
Karolina Valente
CEO at VoxCell BioInnovation
Victoria, Canada